Skip to main content

Compounded medication
Dispensed by a licensed 503A compounding pharmacy
Prescribed only when clinically appropriate

Oral semaglutide tablet bottle503A · CompoundedIllustration only. Actual medication will vary.

Weight Management · Needle-free GLP-1

Oral
Semaglutide

One dissolvable tablet per day. Semaglutide paired with low-dose ondansetron for nausea support, for adults who prefer a daily oral dose over a weekly injection.

503A · CompoundedPhysician-reviewedU.S. pharmacy

Your Plan Options

2 mg

Semaglutide 2 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 30-day supply

$239 /mo

2 mg

Semaglutide 2 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 90-day supply

$649 /3 mo

Best value

6 mg

Semaglutide 6 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 30-day supply

$289 /mo

6 mg

Semaglutide 6 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 90-day supply

$779 /3 mo

Best value

8 mg

Semaglutide 8 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 30-day supply

$309 /mo

8 mg

Semaglutide 8 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 90-day supply

$839 /3 mo

Best value

10 mg

Semaglutide 10 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 30-day supply

$339 /mo

10 mg

Semaglutide 10 mg / Ondansetron 2 mg ODT · 30 tabs/mo · 90-day supply

$899 /3 mo

Best value

Begin your consultation

No charge until a provider prescribes. Prescription required.

Clinical information

What this is, in plain language.

Oral semaglutide ODT combines semaglutide, a GLP-1 receptor agonist, with 2 mg of ondansetron, an anti-nausea medication, in one orally disintegrating tablet taken daily. It is prepared by a licensed 503A compounding pharmacy and dispensed only when a licensed provider determines it is clinically appropriate.

Active ingredients

Semaglutide (2, 6, 8 or 10 mg) and ondansetron 2 mg.

Mechanism

GLP-1 receptor agonist for appetite and glycemic support, with ondansetron to help manage nausea.

Administration

One orally disintegrating tablet daily. Strength adjusted under clinical guidance.

Who it is for

Adults evaluating needle-free metabolic care, when clinically appropriate.

Common effects

Nausea, reduced appetite, constipation, headache. Discuss full risks with your provider.

Important safety & compliance information

Compounded semaglutide / ondansetron ODT is not FDA-approved. It is prepared by a licensed 503A compounding pharmacy and is descriptive only — it is not a branded drug. Product imagery shown here is illustration only; actual medication is dispensed in a pharmacy-labeled container and will vary in appearance. A prescription is required and is issued only when a licensed provider determines treatment is clinically appropriate. This page is not medical advice. Discuss benefits, risks and side effects with your provider.